Concerning plasma markers, some studies have reported higher t-tau levels in patients with bvFTD and PPA compared to healthy controls [219], while a recent meta-analysis has shown that AD patients have higher p-tau values than those with FTD, underlining their potential role in the differential diagnosis [220]. This evidence concerns the gene MAPT and frontotemporal dementia.